Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.3656
-0.0194-5.04%
Volume:1.74M
Turnover:656.26K
Market Cap:24.86M
PE:-0.48
High:0.3955
Open:0.3955
Low:0.3600
Close:0.3850
Loading ...
Aug 23, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 22, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 21, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]